Scholars@Duke
Journal cover image

Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer?

Publication ,  Conference
Dottino, JA; Moss, HA; Lu, KH; Secord, AA; Havrilesky, LJ
Published in: Gynecologic Oncology
June 2018
Published version (DOI) Publisher Link

Duke Scholars

Angeles Alvarez Secord
Author Angeles Alvarez Secord Obstetrics and Gynecology, Gynecologic Oncology

Published In

Gynecologic Oncology

DOI

10.1016/j.ygyno.2018.04.032

ISSN

0090-8258

Publication Date

June 2018

Volume

149

Start / End Page

11 / 12

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dottino, J. A., Moss, H. A., Lu, K. H., Secord, A. A., & Havrilesky, L. J. (2018). Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer? In Gynecologic Oncology (Vol. 149, pp. 11–12). Elsevier BV. https://doi.org/10.1016/j.ygyno.2018.04.032
Dottino, J. A., H. A. Moss, K. H. Lu, A. A. Secord, and L. J. Havrilesky. “Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer?” In Gynecologic Oncology, 149:11–12. Elsevier BV, 2018. https://doi.org/10.1016/j.ygyno.2018.04.032.
Dottino JA, Moss HA, Lu KH, Secord AA, Havrilesky LJ. Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer? In: Gynecologic Oncology. Elsevier BV; 2018. p. 11–2.
Dottino, J. A., et al. “Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer?” Gynecologic Oncology, vol. 149, Elsevier BV, 2018, pp. 11–12. Crossref, doi:10.1016/j.ygyno.2018.04.032.
Dottino JA, Moss HA, Lu KH, Secord AA, Havrilesky LJ. Are FDA-approved PARPi cost-effective as maintenance treatment of platinum-sensitive recurrent ovarian cancer? Gynecologic Oncology. Elsevier BV; 2018. p. 11–12.
Journal cover image

Published In

Gynecologic Oncology

DOI

10.1016/j.ygyno.2018.04.032

ISSN

0090-8258

Publication Date

June 2018

Volume

149

Start / End Page

11 / 12

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3215 Reproductive medicine
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
  • 1112 Oncology and Carcinogenesis